Browse > Article

Clinical significance of serum vascular endothelial growth factor in Kawasaki disease  

Lee, Ho Seok (Department of Pediatrics, College of Medicine Chung-Ang University)
Yun, Sin Weon (Department of Pediatrics, College of Medicine Chung-Ang University)
Jung, Young Soo (Department of Pediatrics, College of Medicine Chung-Ang University)
Chae, Soo Ahn (Department of Pediatrics, College of Medicine Chung-Ang University)
Lim, In Seok (Department of Pediatrics, College of Medicine Chung-Ang University)
Lee, Dong Keun (Department of Pediatrics, College of Medicine Chung-Ang University)
Choi, Eung Sang (Department of Pediatrics, College of Medicine Chung-Ang University)
Yoo, Byung Hoon (Department of Pediatrics, College of Medicine Chung-Ang University)
Lee, Mi Kyung (Laboratory Medicine, College of Medicine Chung-Ang University)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.10, 2007 , pp. 995-1004 More about this Journal
Abstract
Purpose : Kawasaki disease is a systemic vasculitis, leading cause of pediatric acquired heart disease. Vascular endothelial growth factor (VEGF) has functions as vascular permeability factor, plays an important role in coronary artery lesion (CAL). We studied the clinical significance of serum VEGF in Kawasaki disease. Methods : Kawasaki group was 49 patients, and control group was 15 patients. Diagnosis followed AHA (American Heart Association) diagnostic criteria, with blood sampling in acute, subacute, and convalescent phase. Echocardiographic abnormalities were defined and the definition of intravenous gamma globulin (IVGG)-responsive and IVGG-resistant was determined. Results : Serum VEGF of Kawasaki group was significantly higher than of control group. Comparison of serum VEGF between CAL and non-CAL group, between carditis group and non-carditis group showed no significant differences. Subacute serum VEGF was statistically higher in IVGG-resistant group than in IVGG-responsive group, and serum VEGF of IVGG-resistant group in subacute phase was statistically higher than in the other phases. Serum VEGF of convalescent CAL and non-CAL group in acute and subacute phase had meaningful differences. Total fever duration and subacute serum VEGF had positive correlation. Acute serum VEGF had positive correlation with ESR and CRP, all phases serum VEGF had also positive correlation with WBC. Acute and subacute serum VEGF had negative correlations with hemoglobin and albumin. Conclusion : Serum VEGF can help to determine the severity of Kawasaki disease, especially subacute serum VEGF seems to be used as a prognostic factor of coronary complication. Afterward, further studies needed with more strict diagnostic criteria and more study groups.
Keywords
Kawasaki disease; Vascular endothelial growth factors (VEGF);
Citations & Related Records
연도 인용수 순위
  • Reference
1 Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor gene is expressed differentially in normal tissues, macrophages, and tumors. Mol BioI Cell 1992;3:211-20   DOI
2 Seko Y, Imai Y, Suzuki S. Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci 1997;92: 453-4   DOI
3 American Heart Association, Inc. Adapted in part from the Japan Kawasaki Disease Research Committee. Circulation 2001;103:335-6   DOI   ScienceOn
4 Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105(6):E78   DOI   ScienceOn
5 Fukunishi M, Kikkawa M, Hamana K, Onodera T, Matsuzaki K, Matumoto Y, et al. Prediction of non-response to intravenous high-dose gammaglobulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000;137:172-6   DOI   ScienceOn
6 Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease : review of risk factors for coronary aneurysms. J Pediatr 1986;108:388-92   DOI
7 Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10   DOI
8 Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatrics international 2002;44:1-4   DOI   ScienceOn
9 Takeshita S, Kawamura Y, Takabayashi H, Yoshida N, Nonoyama S. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease. Clinical and Experimental Immunology 2005;139:575-9   DOI   ScienceOn
10 Harada K, Yamaguchi H, Kato H, Nishibayashi Y, Ichiro S, Okazaki T, et al. Indication for intravenous gamma globulin treatment for Kawasaki disease. American Heart Association 1993:459-62
11 Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 1993;123:657-9   DOI   ScienceOn
12 Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997; 3:879-86   DOI   ScienceOn
13 Zee R, Murohara T, Lou Z, Zollmann F, Passeri J, Lekutat C, et al. Vascular endothelial growth factor/Vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997;95: 1030-7   DOI   ScienceOn
14 Ferrara N, Henzel WJ. Pituitary follicular cells secret a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8   DOI   ScienceOn
15 Tischer E, Gosporadowicz D, Mitchell R, Silva M, Schilling J, Lau K, et al. Vascular endothelial growth factor : a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 1989;165:1198-206   DOI   ScienceOn
16 Durongpisitkul K, Soongswang J. Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C, et al. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 2003;24:145-8   DOI
17 Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80   DOI   ScienceOn
18 Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrare N. Vascular endothelial growth factor is a screted angiogenic mitogen. Science 1989;246:1306-9   DOI
19 Suzuki A, Miyagawa-Tomita S, Nakazawa M, Yutani C. Remodeling of coronary artery lesions due to Kawasaki disease. Japan Heart J 2000:41:245-56   DOI   ScienceOn
20 Hirose S, Hamashima Y. Morphological observation on the vasculitis in the mucocutaneous lymph node syndrome: a skin biopsy study of 27 patients. Eur J Pediatr 1978;129: 17-27   DOI
21 Burns JC, Glode MP, Clarke SH, Wiggins J Jr, Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of artery aneurysms. J Pediatr 1984;105:206-11   DOI
22 Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease. Circulation 2000;101:2935-41   DOI   ScienceOn
23 Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: clinical observations of 50 cases (in Japanese). Arerugi 1967;16:178-222
24 Burns JC, Wiggins JW, Toews WH, Newburger JW, Leung DY, Wilson H, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 1986; 109:759-63   DOI
25 Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J. et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309-12   DOI
26 Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 2000;154:694-9   DOI
27 Daniels SR, Specker B, Capannari TE, Schwartz DC, Burke MJ, Kaplan S. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. Am J Dis Child 1987;141:205-7
28 Ohno T, Igarashi H, Inoue K, Akazawa K, Joh-o K, Hara T. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2000;159:424-9   DOI
29 Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 2003;143:363-7   DOI   ScienceOn
30 Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995;126: 524-9
31 Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y. Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 1999;83:337-9   DOI   ScienceOn
32 Yasukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y, et al. Systemic production of vascular endothelial growth factor and frns-Iike tyrosine kinase-I receptor in acute Kawasaki disease. Circulation 2002;105:766-9   DOI   ScienceOn
33 Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease : pathology and morphogenesis of the vascular changes. Jpn Circ J 1979:43:633-43   DOI   ScienceOn
34 Ichida F, Fatica NS, Engle MA, O'Loughlin JE, Klein AA, Snyder MS, et al. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York : risk factors and role of aspirin. Pediatrics 1987;80:828-35
35 Beiser AS, Takahasha M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. Am J Cardiol 1998;81:1116-20   DOI   ScienceOn
36 Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajirna I, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998:44:5969
37 Rowley AH, Gonzalez-Crussi F, Gidding SS, Duffy CE, Shulman ST. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987;110:409-13   DOI
38 Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997;100:3131-9   DOI   ScienceOn
39 Mitani Y, Okuda Y, Shimpo H, Uchida F, Hamanaka K, Aoki K, et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation 1997; 96:454-61
40 Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, et al. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 1998;31:1074-80   DOI   ScienceOn